Skip to content
Ep 78 · 54:56

Full transcript

Machine transcribed. Not yet read against the audio.

← Back to the episode
Research use only

Any compounds discussed may be intended for research purposes only. Nothing here is a protocol to follow — amounts, timing and cycle lengths are reported as the named speaker described them.

We are not doctors. Use at your own risk.

534 LINES
Download .txt
Skip the transcript
0:01Speaker 0Low energy? Unfocused?
0:03Speaker 0Foggy? You might be dehydrated.
0:05Speaker 0Whether it's hot yoga, over 100 degree weather, or too much sun.
0:09Speaker 0Gator Lite, with a specialized blend of 5 electrolytes,
0:13Speaker 0was scientifically designed to help move fluids into the body faster for rapid rehydration.
0:18Speaker 0Shop now at retailers nationwide.
0:21Speaker 0Hydrates faster than water. Is it in you? Symptoms noted are signs of mild to moderate dehydration.
0:27Speaker 0Consult a healthcare professional if symptoms persist.
0:31Speaker 1Getting to a great idea is hard in college. Nonsensical essays, cringe inducing presentations,
0:37Speaker 1and seemingly unsolvable problem sets.
0:39Speaker 1But
0:41Speaker 1then,
0:42Speaker 1the 1st thought becomes a final thesis.
0:44Speaker 1Jumbled slides transform into a polished keynote, and that midterm assignment gets a lot less mid. Because the road to great ideas is littered with bad ones. You just have to keep going until something clicks.
0:55Speaker 1Great ideas start on Mac. Find out more on apple.com/college.
1:08Speaker 0Welcome back to the Pep Tide of the Week Podcast. I'm your host, JD Denham across the way, my buddy, my pal, my business partner, my friend,
1:17Speaker 0William Teahawks. What's up, dude? What's up, man? It's Friday. Happy Friday. It is Friday. The time is flying. And today is a special day.
1:26Speaker 0We have a good friend of ours. We like to call him rather, but a good friend of ours. He's been on the show numerous times
1:34Speaker 0and we bring him on when we wanna get the lowdown of what's going on on the streets of peptides.
1:40Speaker 0So you've seen him numerous times if you've been following our podcast in any form for the last year or so.
1:47Speaker 0Paul Bactiar, he is a keynote speaker at multiple peptide conferences. I like to call him the peptide Jedi.
1:54Speaker 3But welcome to the show, my brother. Thank you always, my brothers. I appreciate you both and always appreciate the work that you're doing. Thanks again for inviting me on. Always appreciate being here. Yeah, man. Paul just said, if the world's gonna end, that he's gonna come to us True story. For survival.
2:09Speaker 3Absolutely. I think she's When it all goes down, end of the world, where do you wanna be shoulder to shoulder? I go, there's nobody better than these 2 gents right here.
2:17Speaker 3That's it, baby. As iron sharpens iron, they say. I
2:21Speaker 0love it. I love it. So really quickly, man, how's life? How have you been, man? We all are busy. We catch up from time to time, but just how's life in general, man? How how are things? Things have been good, man. It's been a blessing to be busy. Recently took on a role of, president of telehealth operations for a large medical manufacturer.
2:42Speaker 3In addition to that, still doing all my training, my education. I'll be speaking
2:47Speaker 3at the cell surgical network conference down there in your guys' neck of the woods in Manhattan Beach,
2:52Speaker 3coming up next month. So excited for that. Talking on peptides, things that we all know and love.
2:57Speaker 0Yeah, it's funny, man. I was thinking, I was thinking as we were kind of getting ready for this, that
3:02Speaker 0we're just 3 dorks that like to talk about peptides and compounds.
3:06Speaker 0We could sit here for hours and talking about them for over and over again. It's like, it's cool that we get to sit down and now it's just recorded because these are the conversations we have at dinner. Yeah.
3:18Speaker 0It's really that simple. Like, this is the stuff we talk about when we're hanging out anyway. It's
3:23Speaker 2easy. And it's the way that we have learned, right? It's like by asking questions and talking to people who also know, right? Like people ask me all the time, like, how do I, what do I do in the gym? Right? And like,
3:34Speaker 2how do I get in shape? Like, okay. That's not really a question that you can ask somebody to answer. Right? But I guess 1 of part of that answer is like, go to the gym and watch
3:44Speaker 2people who are better than you. Yep. And
3:47Speaker 2ask them questions. You know what mean? And like, just go watch what exercises they are doing. They're doing something right, obviously. So
3:54Speaker 2basically surround yourself with people who know better than you
3:58Speaker 2or know different than you ask questions instead of guessing and your knowledge and you'll just get better.
4:05Speaker 0Great advice as I like Yeah, to
4:08Speaker 0man. So, well, cool man. Welcome to the show. It is always a pleasure to talk with you and,
4:16Speaker 0you know, we bring you on when we wanna hear kind of the lowdown of what's going on on the streets. The peptide industry is
4:23Speaker 0always a little shaky, always a little gray, always
4:26Speaker 0needing to bob and weave around certain things. And the last time us 3 got together was
4:32Speaker 0at the end of December where there was a lot of chitter chatter of a lot of stuff going down on the streets where
4:37Speaker 0Retatrutide,
4:40Speaker 0all the GLP-1s and things like that. So we had
4:43Speaker 0a great conversation and a lot of the things that we've kind of talked about at that time are kind of to a degree come to fruition
4:50Speaker 0now.
4:51Speaker 0Not to say go us, we just, you know, kind of have some of the foresight
4:56Speaker 0into that stuff. But I do, I want to kind of, you know, me well, man, I want to cut to the jugular and,
5:03Speaker 0know, talk about the big fat elephant sitting in the room that everybody probably wants to hear, which is
5:09Speaker 0what the hell happened to to peptide science?
5:13Speaker 3Yeah. That's a great question. And that just all went down this past weekend, right, where when you went to their website, you would see that it said, hey, we're shutting down shop. Thank you so much for all the years.
5:24Speaker 3So allegedly, and I was next to a
5:27Speaker 3couple of really great attorneys that are in the know as this was happening
5:32Speaker 3in real time. And allegedly, what had happened with them was it had nothing to do with research peptides at all. It actually had nothing to do with peptides whatsoever.
5:41Speaker 3It was allegedly, again, their credit card processing that they were doing offshore.
5:46Speaker 3And it seems that there was something going on where things weren't being reported the way that it should have been, so on and so forth. And again,
5:53Speaker 3the best way I can say is allegedly
5:55Speaker 0this is what's been going down with them. So allegedly, so you don't feel in any way that it had anything to do with the FDA or any type of regulations or anything like that? It was just strictly,
6:08Speaker 0credit card processing.
6:09Speaker 3Absolutely correct, man.
6:11Speaker 2Correct. So let's
6:12Speaker 2stick on credit card processing for a 2nd. Sure. Just
6:15Speaker 2tell
6:16Speaker 2everybody,
6:17Speaker 2so,
6:19Speaker 2everybody, just so you know, like you go to these different peptide websites and not all of them accept credit cards. The reason is- Well, still.
6:27Speaker 2Yeah, is these peptides are handled kind of like cannabis, right? The banks think that customers are super high risk, right? They think that the customers buying peptides are super shady for some reason, doesn't make any sense, but it's a good way for banks to the banks know that there's a lot of money being spent
6:45Speaker 2and they can make a lot of money. And so they're just gonna do their best to tax it. So essentially like you're a, you're a company and you wanna have a credit card processor,
6:53Speaker 2you're paying 10%
6:55Speaker 2of
6:55Speaker 2every dime that you make and they, the bank takes it goodbye, You're
7:00Speaker 2taking another, they're taking another 10%
7:02Speaker 2and paying that back to you 6 months later,
7:06Speaker 2assuming you don't have any chargebacks,
7:08Speaker 2right? So every dime that
7:10Speaker 2a company makes, they take 20% of it right then and there.
7:15Speaker 2And that is if you can be even approved, right? And then you get a processor and it usually stands, it usually is there for maybe a couple months max,
7:26Speaker 2and then it gets shut down. The bank goes, oh, you're
7:31Speaker 2charging too much money or you're accepting just too much money, right,
7:34Speaker 2because you're a business and you wanna accept money. Right? I think that's I thought that was the point, but
7:39Speaker 2nope, you're taking too much money. So we're gonna shut you down and all the money that we have in reserve and all the money that we may still have that we didn't give you frozen 6 We're just gonna freeze that. We're gonna freeze it, not give it to you. Yeah. So you'll see a lot of these product companies
7:53Speaker 2accepting Zelle, Venmo,
7:55Speaker 2catch up, Bitcoin.
7:57Speaker 2And I guess to the viewers, that's not shady. Just realize, I think, you know, a lot of people would say, Hey, if I'm not paying with a credit card, there's something must be wrong. Well, yes, it was wrong, but it's the bank's fault.
8:08Speaker 2But it's not like this. The company is the online company is shady. That's just standard. This is just how those are what people do gotta do to try to make a living,
8:18Speaker 2and to get around.
8:20Speaker 2Yeah. And it's not even, I mean, it's less about the fees, which are crazy.
8:24Speaker 2I mean, not to mention, so 20% gone, then pay another 45% in taxes. There's very little leftover for a company to But
8:32Speaker 2it's more about like, God, the consistency.
8:36Speaker 2Right? And I always had a new process or blah, blah, blah, getting shut down frozen. That sucks. So a lot of companies will just resort to Venmo,
8:43Speaker 2Zelle cash app, and that is what it is. And crypto. Yeah. And
8:48Speaker 2crypto, and I guess direct
8:51Speaker 2like a bank account transfer, right? Enter an account routing number automatically, and then it can get, you know, people have heard that like, or ACM clad that, yeah, it's basically an ACH transfer. All those things are just normal standard practice and don't be alarmed. I mean, always be a good consumer and watch yourself, but
9:09Speaker 0that's about standard for peptides. Yeah. Well said. So just FYI to people. I think most people at this point, because, you know, as we all know sitting here, I mean, peptides have just blown the hell up. I think most people at this point, you know, if we talked a year ago, that would definitely be a different conversation,
9:26Speaker 0but I think most people are getting it, you know, they're, they're most people are getting that's kind of how it works.
9:31Speaker 0Let me ask you this. What do you think? Do you think that's going to stay the same? Do you think it's ever gonna get better? Probably not
9:39Speaker 0because of the gray area that,
9:41Speaker 3those companies swim in. You know, as long as the gray area stays gray, that's pretty much where we're gonna stay when it comes to the banking.
9:50Speaker 3And that's why going back to last end of last year, the last time that we all met, we were speaking about the changes that were happening with with peptides getting approved.
9:59Speaker 3And now we're starting to see that happening. Right? And we knew that all the rage and and it still is quite frankly with Retatrutide,
10:05Speaker 3with the GLP-1s. With Retatrutide
10:08Speaker 3Right. And Eli Lilly, all these companies, big pharma coming in and and really creating the monopoly on Retatrutide,
10:14Speaker 3getting that getting that to go through FDA approval. We really thought that we would see that get FDA approval
10:20Speaker 3earlier this year, and it seems like it's still ongoing. But what we have seen now is, as we mentioned in our last podcast together, about 25 to 40 peptides were gonna start to move out of where they're at in the gray area from the do not compound list. And now Yep. We're seeing about 14 to 19 move into category 1, which means that they're gonna come back into the compounding pharmacies, the 5 0 threes,
10:43Speaker 3where a doctor can write a prescription for those and get that sent out to a patient. So
10:48Speaker 3that's where I see things are gonna continue to move forward in that regard. And the reason why I say that is because as they get more regulations
10:57Speaker 3to move the peptides into the category ones,
11:00Speaker 3that's where they can control it more and they can have the doctor prescription and guess what else comes with that? Credit card processing.
11:07Speaker 0So that's where they're gonna be able to charge and do those things. Somebody listened to the, to the, to the podcast that, that, you know, is kind of new to peptides and just new to this world.
11:17Speaker 0If you can kind of dissect that a little bit, what does that mean to the consumer? Like, what does that mean towards,
11:24Speaker 0towards people that
11:27Speaker 0it just, you know, trying to buy peptides and people that have been going through like a research
11:32Speaker 0peptide company compared to like,
11:35Speaker 0you know, if doctors can actually prescribe
11:38Speaker 0those, what's that gonna do to the market? Great questions.
11:42Speaker 3A little bit, and I know that your viewers, if they've seen this a little watched us a few times, I won't be too much of a broken record, but just a little bit about my past. I was the patient care director for some of the largest online clinics telehealth in the country. Right? So what I would see back in, let's say, 2022
12:00Speaker 3before the do not compound list actually happened for things like Tesamorelin,
12:04Speaker 3BPC,
12:06Speaker 3all of these great peptides that we all know and love. I'll
12:09Speaker 3give you an example.
12:11Speaker 3And it's again, not all telehealth is gonna be doing this, but back then, what what happened was is that 4 months of Tesamorelin
12:17Speaker 3was right around $4,000
12:20Speaker 3supply.
12:21Speaker 3Right? And I remember the number vividly. It was $39.74,
12:24Speaker 3$3,974
12:25Speaker 3for a 4 month protocol of Tesamorelin. Now when you go into a research use website, you're gonna see that same vial of Tesamorelin, for example. Let's you know, I'll just use round numbers. I'm just making it up. Let's just say it's a $100. Right? Just a $100. Okay. So 4 months of Tesamorelin from that kind of a site is gonna be dramatically,
12:47Speaker 3infinitely less than paying 4,000 So
12:50Speaker 3that's gonna be the major difference that that folks will see. The beauty is is that us living in America, we have the freedom of choice. Right? So but the there's there's a Latin saying called caveat emptor, which means buyer beware. Right? That's in everything that that we have here in The United States. So that means that you need to be educated as a consumer to understand where you're getting your peptides from, how you're getting them, where they're sourced from, and is it a trusted source? And then move forward in that regard. But, yeah, that's that's a great question, JD. So when it goes into the 05/2003, the compounding pharmacies, and then it's gonna go through a doctor's prescription, you might see a little bit of a price change. Yeah. I'm thinking like, you know, you gave us the round number and it's about right. So I'd say for about 3 months, Tesamorelin, on a typical research site, you're probably paying about $600
13:36Speaker 2Right?
13:36Speaker 2Maybe 2 bottles a month will get you
13:39Speaker 2about 2 bottles of the last few months. So yes, 600
13:42Speaker 0is a awful lot less than 4,000. 4 A little bit, little bit more hands got to get into the pot through that route. Right? Let me ask you a question, I mean, if the government touches anything, does it get cheaper?
13:55Speaker 0(1h
13:55Speaker 3No.
13:56Speaker 0I'm 48 years old. I haven't seen it yet, but it might be coming. So, Pogg, off the top of your head, tell us,
14:03Speaker 2if you know, what are those 14 to 19 peptides?
14:06Speaker 3Do your best at giving us a list of which ones You know what, I actually wrote the entire list out the other day and if you put a gun to my head,
14:13Speaker 3only 1 that I'll remember right now is BPC.
14:15Speaker 2BPC. Alright. But it's
14:18Speaker 2most of the big popular ones, yes? Is. For sure. Yeah. Okay.
14:23Speaker 0Figured. Yes. Good. So what's that going to do? Because I
14:27Speaker 0mean,
14:28Speaker 0has their favorites and I think, you know, the gateway drug, so to speak, for a lack of a better way to say it, is either BPC
14:35Speaker 0TB-five hundred or
14:37Speaker 0any 1 of the GLP-1s.
14:39Speaker 0You know, a lot of people start there for rightfully so, you know, they, they try those, they work really well. And then they, try multiple
14:47Speaker 0peptides is what, you know, what we see often.
14:50Speaker 0But people are going to want to know obviously about the GLP-1s,
14:55Speaker 0obviously specifically Retatrutide.
14:57Speaker 0What is this going to be? What is this going to mean for that? Like, what does this, this whole, what does all this do
15:05Speaker 0for Retrutide?
15:06Speaker 0It's been supposed to be FDA approved,
15:09Speaker 0it's been pushed out, but as we move forward in 2026,
15:14Speaker 0what's your foresight? What do you think's
15:16Speaker 3happening? What's that going to do to Retrutide? Well, we know what's actually going to happen is once the final approval comes down through the FDA because of all the clinical testing and trials that they've run,
15:26Speaker 3from big pharma on Retrutide, that is their that is gonna be their drug. They own it. They've taken it through all the trials and testing. And that means what does that actually mean when I say that that's their drug? It means that they're gonna be the only ones that are going to be able to compound and supply it. So if you want Retatrutide,
15:43Speaker 3you're gonna be going through Eli Lilly. Right? And they're gonna be the ones that are gonna send it down to the compounding pharmacy from their compounding pharmacy, from the doctor's prescription to go out to the patient.
15:53Speaker 3So does that mean that there's going to be other variations of a triple agonist
15:59Speaker 3glucagon like peptide 1 compound out there that could potentially be mixed with something else?
16:06Speaker 3Of course, there will be. Right? Right. And then how long does that last? We don't know. That's why it's kind of this this guessing game, if you will, where we're trying to see how long you're gonna have access to it. But at the end of the day, will access always be there for Retrutide? Yes. But it will be through the a big pharma and and a doctor's prescription. Will there be other avenues?
16:25Speaker 3Yes. But you don't know how long that'll last. Because if there's 1 thing we know about big pharma is that they don't play around when it comes to their drugs that they paid for.
16:33Speaker 0Yeah,
16:34Speaker 0they're pretty big. Price will skyrocket.
16:36Speaker 0They want run the
16:38Speaker 0price. I mean, it's supply and demand, right? If they have all the supply, they can demand whatever price they want and people will buy it. That's typically how monopoly works, man. Yep.
16:49Speaker 2And I will play devil's advocate real quick. Like,
16:52Speaker 2I know people like, oh, bad, big pharma. Well, I will say that, they did spend a lot of money and develop this drug themselves, and so they do kind of have the right for do the drug. So Yeah. Yeah. And you can understand they there's a lot of bloods blood, sweat, and tears that they put into into that. You're a 100% right, Will. And and 1 thing I wanna mention to you guys, just just to point this out to the audience,
17:15Speaker 3is that,
17:16Speaker 3look, when it comes to peptides, right, and people go, oh, it's not FDA approved, this, that. Okay. So let's break that down.
17:24Speaker 3There aren't vitamin c, b 12, creatine,
17:27Speaker 3protein. None of these are FDA approved either. Right? But we all use them on a daily basis. The other part of this Seriously. Is that when it comes to FDA approval in peptides,
17:37Speaker 3does that mean that a peptide is not gonna be efficacious
17:41Speaker 3or safe, or does it mean that it's not gonna be something that's gonna be life changing just because it's FDA approved? Absolutely not. We all know that. Right?
17:49Speaker 3But what you have to think about is why is it not FDA approved? Let's talk about that just for a moment. Why is it not FDA approved? Well, some of these peptides aren't gonna be FDA approved, not because they don't work fantastically well. It's because there's no money in it for big pharma to do something about it. But why is Retatrutide
18:06Speaker 3and these GLP ones looked at so profitable,
18:09Speaker 3right, and and for them to want to FDA approve it, is because it's actually projected that Retatrutide
18:14Speaker 3alone in the next 10 years is gonna be 1000000000000 dollar compound.
18:18Speaker 3So that's the big difference that I just want the the audience to really think about and know. It's not that they don't work. It's not that they're not safe. It's not that they don't make sense. It's just that there's no money in it for them to want to take it through the clinical trials
18:30Speaker 3for the FDA approval. So that's a big difference, guys. That's
18:34Speaker 2good. That's thank you for that clarification.
18:36Speaker 0Yeah. And that, so that happens. So, so they, it gets FDA approved. Yeah. Lily is the king of the castle, so to speak. What's that do to the other peptides?
18:47Speaker 0What's that do to the rest? What's that do to the other? What does do the like are are like research,
18:53Speaker 0companies
18:54Speaker 0going to be still in existence? Do you think those will fall at the wayside?
18:59Speaker 0What do you think those will do for, smaller companies? No. Great question. So when once that approval happens,
19:06Speaker 3I'll say this.
19:08Speaker 3Will the research companies still be in existence? Yes. But they're gonna be playing that fine line when it comes to things like GLP-1s
19:15Speaker 3and whatnot because if they start to go down the route of making too much noise or marketing in the wrong way when it comes to GLP-1s,
19:24Speaker 3they're gonna get that cease and desist really quick from big pharma.
19:29Speaker 0But,
19:30Speaker 0you know, peptides have grown so fast and so much.
19:34Speaker 0The obvious reason is because they work. They are freaking amazing.
19:38Speaker 0They are healing people
19:42Speaker 0with so many companies. And just like any company, I mean, like
19:46Speaker 0sports companies, you know, where they sell footballs, whatever, some are good, some are bad, right?
19:51Speaker 0But with that many companies able to get access and whatnot, I mean, can they even, I mean, can they dent that many companies? I mean, you know what I mean? They don't have they don't have that much manpower
20:03Speaker 0to be able to stop the sale of that product.
20:06Speaker 3No. And you'll be surprised, right, because the things that they're looking at is who's the biggest players in the industry. Right? So I'll give you guys an example. I have some insider information that I know. And now that Peptide Sciences is defunct, I'll I'll talk about this. But we know that back when we met last time in December,
20:24Speaker 3a couple months before that was was a
20:27Speaker 3a big, we'll just say a big summit. I'll I'll let everybody use their their spidey skills on on thinking about what it is that I'm talking about that went down in DC back in, like, September, October time frame. And
20:39Speaker 3Big Pharma literally told Peptide Sciences, hey, guys. We we've got a cease and desist ready for you guys come January.
20:45Speaker 3Because once January happens, we're not gonna allow you guys to make triple agonist or GLP r, GLP 3, whatever you guys wanna call it because we know what you guys are doing, and that is now gonna be our drug. Right? So that's who they're looking at more than anyone. And as long as
21:00Speaker 0Low energy, unfocused,
21:02Speaker 0foggy,
21:03Speaker 0you might be dehydrated. Gatorade
21:06Speaker 00 powders have been scientifically designed to help improve
21:09Speaker 0balance in the body with a clinically proven electrolyte blend and no artificial colors or flavors.
21:15Speaker 0Great tasting hydration no matter where you're going. Shop now online or at retailers nationwide.
21:21Speaker 3Gatorade hydrates better than water. Is it in you? Symptoms noted are signs of mild to moderate dehydration. Consult a healthcare professional if symptoms persist. These other research companies are doing the doing the right thing and marketing the right way and playing by the rules, they'll be fine. But the 2nd they go into
21:39Speaker 3hitting the pockets of big pharma, that's when they're gonna get in trouble. Peptide Sciences sales were probably responsible
21:46Speaker 2for about, let's just say, you know,
21:48Speaker 2maybe this is kind of even more of an
21:51Speaker 2in proportional eightytwenty rule, but like Peptide Sciences and a few others we're probably responsible for 98%
21:57Speaker 3of the total sales. Probably a safe bet. You know, it was Whichever of that company. That company. It was rumored or or, know, again, I love the word allegedly right now as my attorneys tell me to say it all the time. But it was it was allegedly
22:09Speaker 3they were, they were doing about, you know, dollars $210,000,000
22:11Speaker 3in revenues a year.
22:13Speaker 3Yeah.
22:15Speaker 3Not, not to cut that short, but I heard more about that's, amen. You're doing all right. Yes. Yeah.
22:21Speaker 2And I've had yes. Anyway. And they were taken down by our credit card partner. Yeah. Credit card partner. I guess I wanna touch before we forget, I guess I want could you please clarify the difference between these 14 to 19 peptides that we're saying that you're saying are, you know, being pushed through and
22:38Speaker 2Retatrutide's
22:39Speaker 2approval. Right? There's a huge difference on the approvals. We're not talking about the same approval. Back in 2022,
22:46Speaker 32023,
22:48Speaker 3when big pharma was essentially pulling on the strings of their lobbyists down at the FDA to to tell the FDA, hey, guys. Put all of these peptides on the do not compound list because essentially what they were doing was they were looking into these peptides.
23:00Speaker 3They said for safety, for efficacy, for efficiency.
23:03Speaker 3Some may argue that it was so that they could figure out how to patent some of these or take them through the, the approval process so that they could control it like what we're seeing with with retitrutide. Right? Some may say that.
23:14Speaker 3The thing is is that when it comes down to the difference between what what they're doing with retrutide and getting its FDA approval,
23:22Speaker 3that means that it's gonna be
23:23Speaker 3with a prescription through a doctor, FDA approved, they own that drug.
23:28Speaker 3The 14 to 19 that are now being stated that they're going to put into category 1. So what does that mean? It means that they're taking them off of the do not compound list,
23:38Speaker 3and then they're going to allow the compounding pharmacies, the 5 0 threes that we that we keep mentioning,
23:43Speaker 3allowing the 5 0 3 pharmacies to compound them again the way that they were doing back in 2022.
23:50Speaker 3And I wanna say it was and it stopped back in '23 or maybe it was '22,
23:54Speaker 3because I remember when it was when it happened
23:57Speaker 3because I was still, you know, neck deep in in telehealth at that time.
24:02Speaker 3And when they did that and they put them on the do not compound list, that meant that no doctor, no compounding pharmacy could make them anymore. And that's when they went into really heavily into the research space.
24:13Speaker 0Right. So
24:15Speaker 0again, what's that going to be due to the price? You
24:19Speaker 0know, I'll give you guys a story. Rhetorical to me, but I know there's people asking that don't know. They're always gonna so
24:26Speaker 3the scariest thing in the world to me besides besides, you know, war and everything like that, but 1 of the scariest things in the world to me is when the government knocks on your door and says, hi, we're from the government. We're here to help.
24:39Speaker 0A Reagan
24:40Speaker 3quote, baby. Yeah, man.
24:43Speaker 0Telling it. That's great. With,
24:46Speaker 0with,
24:48Speaker 0peptides just being as amazing as they are,
24:52Speaker 0This is obviously just a personal question. Do you
24:55Speaker 0think they're going to start pushing pharmaceutical
24:58Speaker 0out?
25:00Speaker 0Like, you know, I mean, pharmaceuticals are going to be always be there, but like they work so well and they're so healthy
25:07Speaker 0And,
25:08Speaker 0you know, with some of the pharmaceuticals
25:10Speaker 0that people take, they're destroying our guts. There's such a movement for people to get healthy.
25:16Speaker 0People feel like shit, you know, and like they start taking peptides, they start like, Oh man, I forgot what it feels like to feel good again.
25:25Speaker 0So with the power of
25:28Speaker 0how amazing those are, what's your take on, do you think they're going to push
25:34Speaker 3Western medicine to a degree to the side? I mean, if you break your arm right, you need a doctor, but like, know what I mean? Does that what do you think about that? Brother, I'll say this. We can only hope that it does. Right? We can only hope that it does. And just this last week, a a study came out. Right? This is public information, so everybody can just look this up. There was a document that came out from the CIA
25:57Speaker 3that they had found a cure for for cancer.
26:00Speaker 3Now it's not that they found a cure for cancer that was a big issue. The issue about that document was that it was 60 years old.
26:08Speaker 3Yeah. Yeah. Yeah. You know? So we can only hope that that's what's gonna happen. No. No way. Shocker.
26:14Speaker 0Right? No way. You blew my mind.
26:17Speaker 3The thing is, man, is that when it comes to peptides and the reason why they're so popular and the and the reason why we can only hope
26:24Speaker 3that they will really push Western medicine towards this this route as opposed to, you know, just putting a Band Aid on things with pharmaceuticals.
26:33Speaker 3And the reason why it's happening, guys, is because of guys like you
26:36Speaker 3and the people that are listening to this podcast
26:38Speaker 3and the people that are actually talking to their doctors and bringing it up. Right? Because I can't tell you how many
26:44Speaker 3professional
26:45Speaker 3medical doctors and surgeons that I speak to that don't know about peptides that are now hearing it from who? Their patients,
26:52Speaker 3their clients. Right? And that's what's really pushing this forward. So we just gotta keep up the good work that everybody's doing here with with working from their heart and going, hey. Peptides are great. They're signaling molecules that are actually working and healing people. Let's talk about it. And that's what's making the feds and everybody look at it as well. But But, yeah, we can only hope that it's going to push that Western medicine in that way.
27:12Speaker 0Yeah, Duche. I, it is, it's funny you say that because, know, it's not only that, it's
27:19Speaker 0baffling that
27:21Speaker 0the amount of medical doctors that people go to see and we trust them, you know, we have trusted them now.
27:27Speaker 0I think that trust in the last 6 years or so has been shaken obviously from most people.
27:35Speaker 0But it's amazing the amount of trust that we gave doctors
27:39Speaker 0to just take these pills and, you know, just have destroyed our guts and our gut biomes and whatnot. And it's amazing to me and Will and I talk about this all the time to the point of nausea, but we love it. But even
27:51Speaker 0the fact of the doctors that don't have a clue about any type of hormone levels or like what's a healthy level or
28:00Speaker 0a man that's at 2 50, they won't prescribe
28:03Speaker 0testosterone
28:04Speaker 0replacement.
28:06Speaker 0I mean, now there's a movement and it's just like peptides.
28:10Speaker 0There, some of the doctors that are using the brain are seeing the train coming and they're starting to get it.
28:18Speaker 0And I mean, shoot, we have doctors that listen to this podcast that, you know, like we're not doctors, we're just 2 dudes. We've just, for
28:26Speaker 0lack of a better way to studied it for years because we're so intrigued by it, you know, and it's still studying it that, you know, but we still, like, we do know more about than doctors because they don't open their minds to it. They don't, a of doctors don't even know about nutrition because they've never studied it.
28:42Speaker 0You know, that's, it's just kind of amazing that we've given them so much trust. But like I said, I mean, I think there's such a movement within
28:52Speaker 0the world, at least The United States, but I think the world to get healthy again, truly healthy. I think people are sick of feeling like shit for lack of a better way to say it. And they are seeking different things. That's why this podcast has grown quickly. There's nothing special about these 2 dudes sitting here.
29:09Speaker 0We just have shined a light on some things that people didn't know, and now they are starting to seek deeper.
29:16Speaker 0And it's like that,
29:18Speaker 0that rabbit hole, so to speak, that everybody has to go through and then that cognizant breakthrough that we all finally get through and it's like the world's so different than I thought. You know what I mean? No, man. And you know what, JD, to your point, I want to I want to tell you guys this because, look,
29:34Speaker 3not only do I love working with you guys, but obviously I'm a fan. I watch what you guys do. And the change that's happening right now is when when patients, when people are actually speaking to their doctors and they're bringing up peptides to them. Yep. You need to watch the way that doctor reacts. If they just brush it off, they don't wanna talk about it. Right? That's not a great sign. But if they start to open their mind, they go, oh, well, tell me more about that. Let me do some research and get back to you. That's huge. And my hat is off you guys because I watch your podcast, obviously. I'm a fan 1st and foremost. You guys have had the right kind of doctors, the right kind of medical professionals on your podcast that are talking about this stuff, and they go, oh, yeah, man. I get it. I understand. I see what's going on. I hear you guys. I know what you guys are up to. So that's what really matters, and that's what's pushing this conversation forward for us to, you know, no pun intended, for us to literally make America healthy again. And it's and it's working, man. Yeah. That's true, man. So in my, in my free time, I like to do things that maybe people would say I'm a nerd, but I was like having, I was writing like a mission statement for this,
30:32Speaker 2for this podcast. Right? And
30:35Speaker 2as I thought about it and wrote it more, like literally the mission
30:38Speaker 2for me is to basically, like, further is to further R and D of peptides. Like that
30:45Speaker 2is the mission. Right? These aren't controlled tests, but really to just get out more research and development. Right? Well, research,
30:53Speaker 2with the masses, because that's the only way that we're really gonna people are gonna find out about peptides and how really they work and etcetera, etcetera.
31:01Speaker 2Not to make money like we sure as hell didn't start this podcast
31:05Speaker 2thinking about making money. No. Oh, yeah. But really, yeah, kind of the impetus there is to kind of just further the research and development of peptides in general
31:14Speaker 2and see where that takes us. Yeah. Because there's a whole bunch of good stuff that these things do. Speaking of, did you see did you see the podcast that we did with, with Lee,
31:25Speaker 2who is the owner of the
31:27Speaker 3the name? Yeah. Wellness Center. Service. Yes. That's actually what I was referring to, man. We wanna go raise early on. And I go, well, you guys are getting the right people on there. Their their light bulbs are going off and they get it. Right? And to your point, Will, the other thing I wanna I wanna give you some some some flowers for is the kids are saying these days. Right?
31:45Speaker 3I saw 1 of the posts that you made. I don't know if it was a post or a podcast,
31:49Speaker 3but you were talking about Dihexa, and I couldn't be any more proud of what was going on. So full disclosure to the audience, JD and Will, they they suffered. You know, I was gonna say they suffered through my training of of of all the peptides and stuff, so God bless you guys. But what you're doing with it now, where you've taken it, I go, dude, look at these graphics. Look at what they're talking about. He's talking about the dendrites, the synapses.
32:10Speaker 3I loved it, bro. I was I couldn't move Bro, wait. Yeah. We got more I got more coming. I was just working on, like, comparing.
32:17Speaker 2I I thought frankly that we were gonna do this and do like a compare contrast of the GLPs. And so Yeah. Dude, I got some cool. I got some really cool graphics. But, yes, I I did see that with with Lee. I did see that. Yeah. Okay, cool. Yeah. It's so funny, Paul, because you've known us, you know, from the conception of this company and the
32:38Speaker 0genesis of this is, us being in Vegas and I'm like, Will, we need to sit down and we need to talk about a peptide for like 10 minutes, dude. And then I think it was going to be for my YouTube. And then we did a couple, like we tried doing it on the beach. We were going to do it on a different beach in Orange County. Like, you know, that's how everything starts. You just start tying things and the people are like, I can't hear it. You know? And then like, just started doing it in the night like over, I'd be at my opposite home. He'd be at the office, you know, our old office. And that was just the genesis of it, man. And it's funny because will, Will is just, you know, he was a little bit kicking and streaming doing it because he didn't know this, neither of us had a clue this would turn into even something. We were at a studio now because it's done so well. But it's
33:20Speaker 0because
33:21Speaker 0I believe that when you try to do good, regardless, God puts his hand on it, you know? So
33:27Speaker 0it's been a blessing,
33:29Speaker 0you know, and then we get to touch the people that listen
33:32Speaker 0on the Q and A's because they write in and do this people in Scotland, there's people in like Australia
33:37Speaker 0and it's like, it's rad, man. People are seeking health
33:42Speaker 0all over the world.
33:44Speaker 0To be a little piece of some of that as a blessing, man, all 3 of us, dude, like sometimes, man, would get effects and you meditate and stuff. I'm like,
33:52Speaker 0just look up. Thanks, man.
33:54Speaker 3Appreciate you. God's hands are all over it, Any
33:58Speaker 0new, any new, I know we asked this last time, but, any new peptides coming down the pike? Anything new? Because you always have your,
34:05Speaker 0you know, nose to the grindstone a little bit, you know, and know what's coming down. Is anything new coming? I'll give you guys 1 that I actually just started,
34:13Speaker 32 days ago.
34:15Speaker 3It's it's actually a a
34:17Speaker 3different variation of Follistatin,
34:19Speaker 3FLGR
34:20Speaker 32 2 4, and I may be butchering that a little bit. Campbell talking about this all the time, Jay Campbell?
34:25Speaker 3That 1 you know who, Brian Moscow is? Good friend of mine. He's a biochemist out from UC Berkeley. Super brilliant guy. And he's the 1 that actually,
34:34Speaker 3brought that to my attention, and I've seen some pretty amazing stuff with that, man. Amazing stuff. Guys putting on 20 pounds, and I go, you know what? I'm gonna try that out myself. So I'm that's why I hit you guys up earlier today and I go, hey, man. I I need to pick up some other stuff so that I can I can get this this spring summer body going? You know? We're never doing back from the Arnold Classic, Doug. Yeah, exactly. Exact
34:57Speaker 3being at the Arnold Classic, I go, I gotta get my stuff together, man. Yeah. I'm just kidding. Yeah. No doubt.
35:03Speaker 2Well, that's cool, man. I'm gonna look into that. Yeah. What's the name of that? Did you read that? What's the name of that again? FLGR-two24.
35:09Speaker 2So,
35:10Speaker 2speaking of kind of follistatin issue, so we have a good friend,
35:15Speaker 2who's actually been on this podcast before,
35:18Speaker 2but so you know those Belgian blue bowls? Yes. So you've seen pictures of these bowls that look like somebody's been just injecting them with nothing but steroids forever,
35:26Speaker 2just rippled out with muscles. Well, that is like a natural condition for those bowls. Yep. They,
35:32Speaker 2in their genes, they just have something that does not shut off, doesn't tell them to stop growing muscle, and doesn't tell their body to stop burning fat or at
35:42Speaker 2least their body can't be isn't told to build fat. Right? So doctors
35:47Speaker 2have,
35:48Speaker 2in different countries,
35:50Speaker 2have bottled that
35:52Speaker 2and now offer it as an injection to people. So we had a friend who went down to Mexico
35:57Speaker 2and got the injection of it. And it's supposed to be like that 1 injection, but last year 4 years and changes kind of your, how your genes
36:05Speaker 2work.
36:06Speaker 2That's exciting. You just, that's exciting right there. I don't think he said he felt anything though. He didn't. I think he did. You know, he here's his plan. He's like, yo, yeah, bro. Like, I remember him trying to justify the money portion of it and be like, look, yeah, I know it's 5. It's like $15. Right? But
36:22Speaker 2the all the money I spend on supplements, right, on all of my like tests and peptides, etcetera,
36:28Speaker 2I don't have to do any of that stuff. I just got this. Right? And I just don't think that he really got a good result because of course he didn't stop all the other shots. Was gonna say that. We love you, buddy, if you're listening. I'm
36:39Speaker 2always supposed to say that, but they don't at the end of the day Yeah. Don't stop at all. Yeah. Yeah. And I think at the beginning, I haven't talked to him recently, but he did say he noticed it. Now he sure didn't look. I mean, he didn't put on 60 pounds of just pure muscle, and he was already in good shape. He was all he's always been in really good shape. So I don't know. I don't know if
36:59Speaker 2I don't know how well he really said it worked, but I think he did say it worked a little bit. I know.
37:03Speaker 2Good.
37:05Speaker 31 thing I just was gonna tell you guys that I that I've said for years in all in all the years that I've been in in telehealth and even now when I'm when I'm talking to folks 1 on 1 that asked me about peptides or they might go, hey, man, this kind of didn't work or I don't know if this was working. And I I will point blank look everyone in the eye and I just go, listen,
37:23Speaker 3all these compounds,
37:24Speaker 3these medications, you know, if you're on hormones, peptides, whatever you're on, they're wonderful. They will work. But let me say something, They will only work as hard as you do.
37:33Speaker 3That's it.
37:34Speaker 0Mic drop dude. Like, dude, like you can't sit on the count and chat to not change your life, dude. I mean, we talk about it so much, Paul, like 1st and foremost, if your hormones aren't optimized,
37:46Speaker 0and you're over 40, you're doing it wrong. Like you are swimming up a hill or you're just walking up a hill or swimming and it's a stream, like get your hormones in line and for the love of God, the obvious is workout and eat right. Like
38:00Speaker 0change your darn lifestyle.
38:02Speaker 0And then the peptides will fly.
38:04Speaker 0They will be amazing. They'll amplify.
38:06Speaker 3Know, do that stuff. It might work a little bit. Why would you want it to work a little bit? They're not cheap. Like, if you're gonna do it, do it well. 100%. And you're the shining example of that, JD. You actually live and walk it and talk it and do you practice what you preach, basically, is what I'm saying. And the thing is is I go I go when people tell me, oh, I just lost, like, 8 pounds, and I go, you lost 8 pounds and did nothing? I go, 1st of all, that's amazing.
38:29Speaker 22nd of all, imagine if you actually did something, like, how much more you would lost and how much better you would have felt. So yeah, man. Or we hear this a lot. Like, it's just it didn't do anything for me. You know? I've only lost 20 pounds in 2 months. Like, it doesn't work.
38:43Speaker 0Seriously. It's only 20
38:45Speaker 0pounds. You're listening to yourself. Right? Yeah. How long did it take you to gain that weight? Anyway,
38:49Speaker 0yeah, agreed. Agreed. It's like funny because, you know, any GOP-1will
38:54Speaker 0give instant gratification,
38:56Speaker 0but it's like, I want more.
38:58Speaker 0Sit on the couch and I'll do shit, eat some Twinkies and lose 50 pounds in a week. If only.
39:04Speaker 2Yeah. So, hey Paul, what are your personal
39:08Speaker 3top 5 peptides? Just how about in life, what do you actually take? What are your top 5 peptides that you'd mostly take? Let me take a jab at this. Well, right now what I'm doing Do wanna guess? Great. I love this question because you guys already know. I was we were talking before we started the podcast. I was like, hey, guys. I gotta get my stuff together. You know? And and thanks for pointing that out that that it was Arnold Classic that did it to me. That was a good motivator right there. But Yeah. The I'll tell you. For me right now,
39:33Speaker 3what I'm taking is I'm taking SLUIP,
39:35Speaker 3right, the exercise mimetic.
39:37Speaker 3Really like that 1. I take a milligram of that, in the morning fasted.
39:40Speaker 3And then I take that with 150 mg of 5 amino 1 m q, oral, both of those.
39:45Speaker 3That's gonna go after the white adipose tissue, that that stubborn body fat. Right? Because Oh, yeah. You know, hey, man, I'm I'm Persian. I'm 44. I keep the love handles no matter what I do. So I that that those 2 right there helped me out tremendously.
39:58Speaker 3While I'm doing that, of course, I'm like everyone else where I'm trying to lose body fat and gain muscle. So what did I add into that? What'd you to add? Was the FLGR that we were just talking about. Got
40:08Speaker 3that going and
40:10Speaker 3a little bit of Tesamorelin
40:11Speaker 3in addition to my 200 mg a week of test Scipionate bio identical from my TRT. So that's what I'm doing right now.
40:19Speaker 3Hell yeah. Thank you. Right
40:23Speaker 3now I go, you know what, let me get this going and then I'll start to microdose Red at about a milligram, maybe a week, every other week. Because I'm such a small guy, I'm only like five'nine, 180 pounds. I'll wither away, you know? Yeah. Yeah, for sure. Hey, now speaking of Dihexa, so in my, the presentation and podcast we did, like Dihexa is not
40:42Speaker 2kind of 1 of the main points there was like, this isn't something you don't take this for like, I want to take it right now and my brain is going to be bang firing, right? Like Modafinil.
40:51Speaker 2Okay.
40:52Speaker 2It's a
40:54Speaker 2that being said,
40:56Speaker 2you, I know that you have taken it like before a presentation to make it to for instant results. I also was just literally last night was talking to an employee of ours and she said,
41:06Speaker 2dude, the Dihexa is awesome. She feels it right away and focus.
41:12Speaker 2And I thought that was interesting. It just just shows again, like the research that we do is like,
41:18Speaker 2you know, you can say 1 thing on on paper. Yeah. But
41:21Speaker 2but actually when people take it Yeah. Yeah. Oftentimes things are a bit different.
41:26Speaker 2I think that's cool. Now I do think it's against one-
41:30Speaker 0Low energy, unfocused,
41:32Speaker 0foggy,
41:33Speaker 0you might be dehydrated. Gatorade
41:36Speaker 00 powders have been scientifically designed to help improve hydration balance in the body. With a clinically proven electrolyte blend and no colors or flavors.
41:45Speaker 0Great tasting hydration no matter where you're going. Shop now online or at retailers nationwide.
41:50Speaker 0Gatorade hydrates better than water. Is it in you? Symptoms noted are signs of mild to moderate dehydration.
41:56Speaker 2Consult a healthcare professional if symptoms persist. Things where it may not work for me that great because I take too many stimulants, right, and drinking coffee too much. There's too much thing, too many things that are actually overpowering
42:08Speaker 2it. But
42:10Speaker 2like her,
42:11Speaker 2she was very clear, like she's clear and isn't taking much at all, just added Dihexa and damn, she said she notices it a lot.
42:19Speaker 3Is a great question. And I've dealt with this a few times. So
42:23Speaker 3I like to pair Dihexa with a couple of other peptides. Right? So if it's someone that goes, hey. So I'll give you guys an example.
42:31Speaker 3There was a patient years ago when I was when I was at a different telehealth company that he was going through med
42:39Speaker 3law school, I believe is what it was. He was in law school. And he's like, Paul, he goes, I I don't wanna take Adderall. I really wanna take something that's gonna be natural, something that's a peptide. What can I do?
42:50Speaker 3So for him, what we did was we did 30 mg
42:53Speaker 3of Dihexa daily,
42:55Speaker 3and then we paired it with either I think we started them off at 0.5 a milligram of Tesofensine and worked our way up to a full milligram of Tesofensine.
43:02Speaker 3You put those 2 things together,
43:04Speaker 3that's just fireworks going off in your brain. And you you're able to
43:09Speaker 3not only focus,
43:10Speaker 3but you're able to pay attention. And also the best way they can explain is you can move from task to task very easily without
43:17Speaker 3slowing yourself down. So Tesofensine
43:20Speaker 3being that it's it's what we would call like a natural SSRI
43:24Speaker 3kinda gives you an overall sense of well-being. You feel happier. But what it's really doing to give you a great kick of energy
43:30Speaker 3is it's raising your basal metabolic rate, is your your your rate at rest. Right? So it brings that up by about 5 to 10%.
43:38Speaker 3And Sure.
43:39Speaker 3It's a great appetite suppressant. So, also, that's just a kind of a pro tip for anybody that's getting off of a GLP 1 that's a little bit nervous about, hey, I don't wanna put on, you know, weight again. Bring in Tesofensine.
43:49Speaker 3And when you pair it with Dihexa,
43:51Speaker 3that's incredible. That's quite frankly, guys, full disclosure, that's how I've gotten through so many seminars. Let me tell you. All these seminars and conferences I've been to is, yeah, the Dihexa and Tesofensine.
44:01Speaker 0And then,
44:02Speaker 3to your point, Will, and I know we've we've talked about this before, when I'm presenting and when I'm actually speaking,
44:08Speaker 3for for doctors that receive their continuing education credits on peptides,
44:12Speaker 3that's where my nerves kick in. Right?
44:15Speaker 3Because as you guys said, none of us here are are MDs or DOs. Right? So the thing is is that I will always cite all of my work, do the clinical research, show the peer reviewed medical studies.
44:26Speaker 3And as I'm going through that, when I'm on stage talking to a group of, like, a 100 doctors, you know, nerves start to kick in a little bit. So what do I do in that in that regard? Was, well, I like to pair Selank,
44:36Speaker 3which is an antianxiety
44:37Speaker 3peptide with Dahexa. Keep me focused, make me feel like right where my feet are at. And that, that that's a really great combination, but Dahexa is fantastic. So
44:47Speaker 3the reason why Dahexa is a really incredible
44:50Speaker 3peptide is because they're studying it for Parkinson's,
44:53Speaker 3for Alzheimer's, for dementia. And I've actually seen the effects on on a
44:58Speaker 3a person with dementia, a really good friend of mine. His father was 81 years old. He since passed. But before he passed a good year or 2 before that, we
45:08Speaker 3actually had him on on quite a few peptides and brought him back from dementia.
45:13Speaker 3He was actually yeah. It was incredible, man. We we did a lot of things for him. Huge. Yeah. What was the dosage? What was the daily dose orally that you guys At 30 I gave milligrams. And that's and just so that you guys know,
45:26Speaker 3before these peptides went on the do not compound list,
45:29Speaker 3because you gotta remember, since since my days in in all of the the telehealth companies that I've been at, so there's something called the SOAP notes, subjective assessment
45:39Speaker 3plans, right? That's what the doctors write in every chart for a patient.
45:44Speaker 3So within those SOAP notes, what's going to be in there is dosing, timing, frequency. So the dosing, timing, frequency that I'm always speaking about is actually what was clinically
45:52Speaker 3recommended and prescribed
45:54Speaker 3at the level of telehealth for these peptides before they went on the do not compound list. So what were we talking about for Dihexa back then? 20 to 30 mg a day. For how long? We
46:05Speaker 3would prescribe everything in 4 month increments. Every peptide I'm always gonna recommend 16 weeks.
46:10Speaker 0Yep. Okay. Got it. Nice,
46:12Speaker 3man.
46:13Speaker 0Oh, I got last question. So I was curious.
46:17Speaker 0And you kind of answered it, but I want to kind of still ask it.
46:21Speaker 0You know, there's still people that, you know, are so,
46:24Speaker 0so
46:26Speaker 0don't know anything about peptides and they compare them to steroids and all that stuff, right?
46:31Speaker 0How far away, and you kind of answered it with FLGR,
46:34Speaker 0but how far away do you think science is of getting
46:41Speaker 0peptides into the degree where they somewhat compete
46:44Speaker 0with like some Anovar or smaller steroids that
46:49Speaker 0are going to give you some bulk? I mean, you know, IGF-one, I mean, there's a, know, you know what I mean? But like, we're so far away from like gear that like,
46:57Speaker 0do you think that's gonna happen, I guess, is the 1st question. The 2nd is, if so,
47:02Speaker 0when roughly?
47:03Speaker 3So,
47:05Speaker 3again, you guys I love the questions. I was just about to say great question. I'm I'm like a broken record every time you guys ask me something, but that was a great question. So the thing is is that
47:15Speaker 3there's variations of what we can do with peptides that are gonna be much safer than what we can do with hormones.
47:22Speaker 3Right? So
47:23Speaker 3so I'll give you guys, an example because and to answer your question, we already are
47:28Speaker 3kind of competing a little bit in in that regard when it comes to peptides and hormones.
47:32Speaker 3But hormones are are different in the sense that they're controlling
47:36Speaker 3the entire body, right, to where the peptide is controlling a specific mechanism, and it's actually getting the body to perform naturally the way they want. So they're just signaling molecules. But I'll give you guys an example because remember, also my background
47:50Speaker 3is in is also from sports supplements and bodybuilding years ago, right, when I was head of marketing for a really big
47:57Speaker 3supplement company.
47:58Speaker 3So
47:59Speaker 31 of the things that bodybuilders really love is growth hormone paired with insulin.
48:05Speaker 3Right? That's a big 1 because that's going to put a lot of size on you, a lot of mass on you. It's going to get you going. It's going raise your IGF levels. So but it's raising your IGF levels exogenously from outside the body, right, not in a natural way the way that a growth hormone releasing peptide will. Well, what's the peptide equivalent
48:21Speaker 3of GH and SLN? Well, the peptide equivalent that I've actually seen work very well would be MK-six 77, which is ibuprofen,
48:29Speaker 3and IGF LR3.
48:30Speaker 3Because ibuprofen is gonna kick up your IGF levels, it's gonna make you hungrier, produce more ghrelin, which is a hormone that that's telling you you're hungry. And then you pair that with IGF LR3, so it's shuttling the nutrients and and food to the muscles that breaking down.
48:43Speaker 3The equivalent right there. Now, is it exactly the same? Absolutely not. Does it work in the same regard using the same mechanism of actions? Yes, it does. It's pretty incredible. Do
48:53Speaker 3I think that we'll eventually get to a point toward these that the peptides can
48:58Speaker 3do exactly what the hormones do?
49:00Speaker 3I don't know.
49:02Speaker 3That's a great question. Don't know if we'll get there. I don't know if we wanna get there because we we can always use the replacement therapies of the hormones to do that. But what we are doing with peptides is getting the body to perform naturally the way that it wants to by kicking on its own growth hormone release, whatever it is that we're doing. So like Kisspeptin's bringing up the testosterone,
49:21Speaker 0things of that nature. But yeah, I love that question. Yeah, I'm sorry. Last 1, because now just I'm actually curious.
49:27Speaker 0So we get a lot of questions
49:30Speaker 0about
49:31Speaker 0high school kids. Okay. And now peptides are so big that,
49:36Speaker 0you know, we have a lot of parents ask us about our opinions on like growth hormones, cretagogues and whatnot. And
49:43Speaker 0without me, us telling you our answer,
49:46Speaker 0what is your take on that? You have a high school dad that his kid has a great arm and he wants to go, he's going pro, my kid's going pro, you know, like every father thing. And he's 12. Yeah,
49:57Speaker 0right.
49:58Speaker 0But let's at least say teens, 15. Let's say 15. 15, 16.
50:02Speaker 3What would you say? What's your opinion on that? I've actually dealt with that exact scenario that you just gave me. Baseball. I've dealt with the baseball bat. Yep. I dealt with that while I was at
50:12Speaker 3the the largest telehealth company
50:15Speaker 3in in the country, right, years ago. You're going back maybe, like, 5 years ago, something like that.
50:21Speaker 3So so the so I'll always because, again, I gotta deal with attorneys all the time. So we're gonna go with the legal answer is anyone who's under 21 years old, you can't recommend okay. Now let's talk about if it was my kid. So let's make it personal. Right? Perfect. Let's talk
50:35Speaker 3about my kid.
50:36Speaker 3Now that's going to be at the discretion of the parent of now the the kid that I'm talking about, he was 17 years old, so he was kinda like right there at that cusp of being 18 and getting in that range. And the dad was like, hey, man. I'm ordering CJC for myself.
50:51Speaker 3And I if I wanna give this to my kid, what do you think? I go, well, look, man. Your kid's already making enough growth hormone as it is. I don't see that something that you should be doing, but you're his father. That's up to you. It's whatever you But wanna
51:05Speaker 3let's take it a step further, guys,
51:08Speaker 3that if it was my kid and he got injured. Let me talk about that. Yeah. Okay. So if he got he or she, God forbid, got injured. Because I have dealt with this.
51:17Speaker 3Folks will ask me this all the time. Hey. You know what? My kid's knee, ACL, MCL, their labrum, whatever it was. Again, not legal or medical advice, but if it was my own kid and they're 16, 17, 8, whatever it is, would I give them BPC?
51:32Speaker 3Would I give them TB-five 100? There's no question in my mind that I absolutely would. A 100%.
51:38Speaker 0You answered it to the T how you answered it. That's great.
51:43Speaker 0Either of my sons, I would give them the Wolverine.
51:47Speaker 0To this day, my brother, I have, I have, I have thrown out your protocol
51:51Speaker 0because everybody in the like that's watches knows that I have had back surgeries. So they're always asking I'm glad to help you. I hope a
51:59Speaker 3lot, take a lot because it worked well. Was in the gym 2 weeks later and lifting. I love it, man. That's what it's about being able to help everyone out there, man. I appreciate that. But yeah, girl, my dog, I give my dog 1 more time. No doubt.
52:13Speaker 2My dog also. So I gave my dog a lot of, TB-five 100
52:18Speaker 2and I should have given him more
52:22Speaker 2anti cancer
52:23Speaker 2because that's what killed him.
52:25Speaker 2But that's inevitably,
52:26Speaker 2you know, you've met my dog. Oscar was big. He
52:30Speaker 2he was great.
52:31Speaker 2Still running up trees. He was about a 100 pound like Pitbull Rottweiler mix and had a seizure on a Sunday night. By next, by the following Thursday, I put him down and apparently he had cancer in his stomach,
52:44Speaker 2lungs, and then brain, which is what caused the seizure. But TB-five hundred, a lot of the tests, you know, the research actual like R and D and TB-five hundred is on canines.
52:55Speaker 2For his, he tore both his ACLs at 1 point, but 1 of them, I didn't have surgery. I just threatened him like, dude, you need to heal this leg or I might were cutting it off. But I did this $6,000
53:06Speaker 2surgery for the 1st knee, and then he tore the 2nd 1, but I never did anything. I gave him
53:11Speaker 2some TB-five hundred injections, man. He healed and never like limped. Wow. Was never bow legged. You see a lot of dogs who,
53:19Speaker 2they tore their ACLs in in no surgery and they're kind of walking bow legged now or limping. I mean, he got old 12,
53:25Speaker 213 years old and just never even had any leg problems, even tearing both ACLs.
53:30Speaker 3It definitely works, man. And you know what? A good friend of mine, you guys also know Trevor, he he recently,
53:35Speaker 3adopted a Saint Bernard, and he thought that the Saint Bernard's hip was was off. He didn't know what was going on, like it had hip dysplasia.
53:42Speaker 3Well, he started giving his dog BPC,
53:44Speaker 3and now he's running up on tables. He can do anything he needs to do. It's it's it's pretty incredible. And also, Will, to your point,
53:52Speaker 3you know, 1 of the things that that I will always mention to folks, you know, battling the big c word, right, is,
53:59Speaker 3let me say this, in 50 countries around the world, thymosin alpha-one is used in oncology.
54:07Speaker 3So do with that information what you want audience, but but do some research on that. I just want you guys to at least be aware of that because that's a big 1. And some of the oncologists, the more forward thinking ones, especially actually in California,
54:19Speaker 2they are starting to incorporate thymosin Alpha-one in their treatments. That stuff's amazing. I love it. What about that? I forget the name of the actual drug, the pharmaceutical drug that it is, that it's under, but yes, in all these different countries, we did, we did 1, we did a, we did a peptide of the week on Thymosin Alpha somewhat recently. Love it.
54:40Speaker 0I mean, right on dude. Well, man, we love you brother. I mean, we could talk forever. Have multiple questions, but we have, we obviously
54:47Speaker 0will have you on. We'd love you to get in here next time. Next time you got my word, I'll be in there. I'll come down We've the road.
54:53Speaker 0Done in the studio that we have you on the screen. So as you listeners and people on Spotify and YouTube are watching, we might be looking a little weird in different directions because it's our 1st time. We'll get that dialed in because he will not be the 1st that we do this with. Yes. We're just used to sitting, talking to each other, but we'll get a hologram. We're going to get a hologram of you sitting
55:13Speaker 0there.
55:14Speaker 0High 5 next
55:15Speaker 3week. Get the AI do version of it. That'll work great, man.
55:19Speaker 0Love you, man. I love your stuff. You watch it all the time, man. The Jedi. So tell everybody as we close out,
55:25Speaker 3where can they find you? Thank you. You, it's just my name at Paul Bakhtior and Bakhtior is B A K H T I A R across all socials guys. Thank you so much.
55:37Speaker 3Awesome, man. And we're gonna get you, Paul, to,
55:42Speaker 2respond, give us some a little bit of input in our elite,
55:45Speaker 2in our, like, warrior elite
55:48Speaker 2new platform, which you don't really know anything about it, but we're gonna get you some people who are part of that. Yeah. We'll get Paul to to to pop in there every once in a while. We will. People that we we do wanna talk about that before I suppose I forgot. We have just dropped the, warrior,
56:03Speaker 0platform.
56:05Speaker 0We we got tired of getting
56:07Speaker 0shadow banned. We got tired of getting things taken down. We got tired of big brother's easiest way to say it. So we built our own platform and we released it 2 days ago and it's exceeded our expectations by a mile. We're blown away by how many people are joining and people are not just joining, they're posting, they're lifting each other up. They are talking. Oh man, it is just a raddest community.
56:27Speaker 0So join it. We're gonna put the links all over. Shoot us DMs, we'll get you in, but get in and you're gonna have access to us, guys like Paul and a lot of other stuff that we can't say on social media, so you wanna do it. So that
56:41Speaker 0is it for the day, my friends, and we will catch you next time.
56:45Speaker 3Thank you, guys.